Velocity Clinical Research, a leading name in the clinical research industry, is headquartered in the United States and operates across multiple regions, including key markets in North America. Founded in 2016, the company has rapidly established itself as a trusted partner for pharmaceutical and biotechnology firms, specialising in Phase I-IV clinical trials. Velocity Clinical Research offers a comprehensive suite of services, including site management, patient recruitment, and data management, distinguished by its commitment to innovation and efficiency. The company’s unique approach to patient engagement and streamlined processes has positioned it as a frontrunner in the clinical research landscape. With a focus on delivering high-quality results, Velocity Clinical Research continues to achieve notable milestones, solidifying its reputation as a reliable collaborator in advancing medical science.
How does VELOCITY CLINICAL RESEARCH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
VELOCITY CLINICAL RESEARCH's score of 3 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Velocity Clinical Research, headquartered in the US, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or may not have publicly disclosed its emissions strategy. In the context of the industry, many organisations are increasingly focusing on sustainability and setting ambitious targets to reduce their carbon footprints. However, without specific information, it is challenging to assess Velocity Clinical Research's position in this regard.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
VELOCITY CLINICAL RESEARCH is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.